Clinical Trial Update: SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma [Phase 1]

View source ↗

Summary

Phase 1 trial of SU5416 (Semaxanib) in AIDS-related Kaposi's sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aids-related Kaposi Sarcoma
• Kaposi Sarcoma

Drugs mentioned

• SU5416 (semaxanib)

Snippet

Sponsor: Pfizer | Conditions: Sarcoma | Phase 1 | Status: COMPLETED